Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
1.
Asian Pacific Journal of Tropical Medicine ; (12): 884-888, 2013.
Article in English | WPRIM | ID: wpr-819954

ABSTRACT

OBJECTIVE@#To explore the effect of sustained-release recombinant human bone morphogenetic protein-2 (rhBMP-2) on ectopic osteogenesis in the muscle pouches of rats through preparing rhBMP-2 sustained-release capsules by wrapping morphogenesis protein bones-2 (BMP-2) using chitosan nanoparticles, and compositing collagen materials.@*METHODS@#Twenty four Sprague-Dawley rats were randomly divided into four groups with six rats in each group, that is Group A (control group), Group B (only treated with collagen), Group C (rhBMP-2+collagen treated group) and Group D (rhBMP-2/cs+collagen treated group). The composite materials for each group were implanted in the bilateral peroneal muscle pouches in rats. The peroneal muscles were only separated without implanting any materials in control group. Rats were sacrificed 2 weeks and 4 weeks post treatment and samples were cut off for general observation, Micro CT scans and histological observation.@*RESULTS@#General observation showed no new bone formation in Groups A and B mice, while new bones were formed in Groups C and D mice. Two weeks after treatment Micro CT scans showed that The bone volume fraction (BVF), trabecular thickness (Tb.Th), bone mineral density (BMD) in Group C mice were all higher than that in Group D (P<0.05). At the fourth week, the BVF, Tb.Th and BMD were significantly higher than that at the second week (P<0.01).@*CONCLUSIONS@#The slow-release effect of rhBMP-2/cs sustained-release capsules can significantly promote ectopic osteogenesis. Its bone formation effect is better than that of rhBMP-2 burst-release group.


Subject(s)
Animals , Rats , Bone Morphogenetic Protein 2 , Pharmacology , Collagen , Pharmacology , Delayed-Action Preparations , Pharmacology , Drug Carriers , Pharmacology , Intercellular Signaling Peptides and Proteins , Muscle, Skeletal , Nanocapsules , Osteogenesis , Rats, Sprague-Dawley , Recombinant Proteins , Pharmacology , Tissue Engineering , Methods , Transforming Growth Factor beta , Pharmacology , X-Ray Microtomography
2.
Asian Pacific Journal of Tropical Medicine ; (12): 406-409, 2012.
Article in English | WPRIM | ID: wpr-819662

ABSTRACT

OBJECTIVE@#To investigate the feasibility of ultrasonic diagnosis for monitoring fracture healing.@*METHODS@#Thirty rabbit models with fraction of mandible body were established by surgically removing partial lower jawbone. At the 1st, 2nd, 4th, 6th, 8th and 12th week after the operation, they were examined by X-ray and ultrasound, respectively. All detection results were scored according to a generally accepted standard. Spearman rank correlation analysis was conducted to explore the relationship between the results of the two inspection methods.@*RESULTS@#In each healing stage, the results of the ultrasonic inspection were basically consistent with those of the X-ray examination, as supported by a Spearman rank correlation coefficient of 0.892 (P<0.001).@*CONCLUSIONS@#Non-invasive ultrasonic inspection can be used instead of X-ray examination to monitor and diagnose fracture healing.


Subject(s)
Animals , Rabbits , Disease Models, Animal , Feasibility Studies , Mandibular Fractures , Diagnostic Imaging , General Surgery , Radiography , Random Allocation , Ultrasonography , Wound Healing , Physiology
3.
West China Journal of Stomatology ; (6): 464-467, 2010.
Article in Chinese | WPRIM | ID: wpr-350309

ABSTRACT

<p><b>OBJECTIVE</b>Using chitosan (CS)/beta-tricalcium phosphate (TCP)/recombinant human bone morphogenetic protein (rhBMP)-2 for the reconstruction of rabbits' mandible defect, to prove the feasibility of CS/beta-TCP as an injectable bone tissue engineering scaffold material.</p><p><b>METHODS</b>Twenty-four New Zealand white rabbits were randomized into 4 groups on average: Experimental group 1 embedding CS/beta-TCP/rhBMP-2, experimental group 2 embedding CS/ beta-TCP, control group 1 embedding autograft bone group, control group 2 embedding nothing. At 2, 4 and 8 weeks after surgery, all rabbits were executed group by group. The new bone growth situations were observed with hematoxylin-eosin staining and immunofluorescence microscopy, the bone mineral density was detected by bone sonometers.</p><p><b>RESULTS</b>After 2, 4, 8 weeks, there was significant difference among the areas of bone regeneration of all groups. The effect of experimental group 1 was better than experimental group 2. There was significant difference at different times, the areas of bone regeneration was gradually increased with time. The area of stained yellow in experimental group 1 was larger, the area of stained red was smaller. The quantities of bone density in experimental group 1 at every time after surgery were significantly higher than experimental group 1 and control group 2, but had no statistical significance with control group 1.</p><p><b>CONCLUSION</b>CS/beta-TCP/rhBMP-2 has good biocompatibility, degradability and the capacity of guided and inducing osteogenesis. CS/beta-TCP as a good injection of carrier could become a promising carrier for rhBMP-2 and potential new degradable biological material for repairing bone defect in clinical application.</p>


Subject(s)
Animals , Humans , Rabbits , Bone Morphogenetic Protein 2 , Bone Morphogenetic Proteins , Bone Regeneration , Bone Transplantation , Bone and Bones , Calcium Phosphates , Chitosan , Osteogenesis , Recombinant Proteins , Tissue Engineering , Tissue Scaffolds , Transforming Growth Factor beta
SELECTION OF CITATIONS
SEARCH DETAIL